Skip to main content

Advertisement

Log in

CRISPR germline engineering—the community speaks

  • Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

Nature Biotechnology asks selected members of the international community to comment on the ethical issues raised by the prospect of CRISPR-Cas9 engineering of the human germline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Supplementary information

Supplementary Text and Figures

Supplementary Comments (PDF 454 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bosley, K., Botchan, M., Bredenoord, A. et al. CRISPR germline engineering—the community speaks. Nat Biotechnol 33, 478–486 (2015). https://doi.org/10.1038/nbt.3227

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3227

  • Springer Nature America, Inc.

This article is cited by

Navigation